ReviewCancers2022

Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study.

Alessandro Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.